Manipal Health Share Price & Stock Analysis

Quick Answers

What is the Manipal Health share price today? Manipal Health is currently listed and trading. Check our charts for the latest listing performance.

Is Manipal Health a good stock to buy? Review our AI forensic scores and fundamental analysis for Manipal Health to understand the underlying financial health.

Key Stock Information

ViewIPO AI Analysis Score

The Manipal Health Stock scored 55/100 (High Risk) in our deep analysis.

Frequently Asked Questions

What is the issue size of Manipal Health Enterprises Ltd IPO?

The issue size of Manipal Health Enterprises Ltd IPO is ₹9,275.22 crore, which includes both fresh issue and offer for sale (OFS) components.

What is the price band for the Manipal Health Enterprises IPO?

The price band for the Manipal Health Enterprises IPO is ₹560 to ₹590 per share for regular investors, with a discounted band of ₹504 to ₹534 for eligible employees.

How will the proceeds from the fresh issue be utilized?

Net proceeds from the fresh issue will be used for repayment/prepayment of certain outstanding borrowings and accrued interest availed by Manipal Hospitals Private Limited (₹5,378 crore) and acquisition of minority stake in Sahyadri Hospitals Private Limited (₹574 crore), with the balance for general corporate purposes.

What is the bed capacity of Manipal Health Enterprises as of March 31, 2026?

As of March 31, 2026, Manipal Health Enterprises operated 49 hospitals with a total of 13,037 licensed beds across 14 states and Union Territories in India.

What accreditations does Manipal Health Enterprises hold?

As of March 31, 2026, 41 of its 49 hospitals were accredited by the National Accreditation Board for Hospitals and Healthcare Providers (NABH), and 24 hospital laboratories were accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

Who are the Book Running Lead Managers for the IPO?

The Book Running Lead Managers are Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited, UBS Securities India Private Limited, and DBS Bank India Private Limited.

What was the company's profit after tax in FY26?

The company's profit after tax in FY26 was ₹916.52 crore.

What is the lot size for the Manipal Health Enterprises IPO?

The lot size for the Manipal Health Enterprises IPO is 25 shares.

View IPO
View IPO
Home›India›Manipal Health ()
Manipal Health Logo

Manipal HealthNSE / BSE:

Analyzed by ViewIPO Financial Research Team
HealthcareIndiaFiled 2026-07-29Listed 2026-08-05Size ₹9275.25Cr
Lot Size 24
Listing Return
₹62.01 (+10.51%)
Live Subscription
4.9x Total
Check Allotment
Status Link

Is Manipal Health a Good Stock? Quick Verdict

Manipal Health IPO scored 55/100 (High Risk) in our deep analysis. The strongest pillar is Dilution at 70/100, while Governance is the primary concern at 39/100. Manipal Health Enterprises Limited presents a strong IPO opportunity backed by its position as one of India's largest private multispecialty hospital networks, consistent revenue growth, and improving profitability, though investors should monitor debt levels and the moderation in net profit growth in FY26.

Stock Score
55/100
High Risk

Quick Verdict

Revenue grew at a CAGR of 29.4% from FY24 to FY26, reaching ₹10,335.75 crore in FY26.
ROCE stood at 21.88% and RoNW at 10.57% for FY26, indicating efficient capital utilization.
The company operates 49 hospitals with 13,037 beds across 14 states, making it one of India's largest private hospital chains.
Profit after tax declined from ₹1,081.67 crore in FY25 to ₹916.52 crore in FY26, indicating moderation in profitability.
Debt levels are not explicitly disclosed, raising concerns about leverage despite plans to use IPO proceeds for debt repayment.

Company Snapshot

Revenue (TTM)
₹10335.75Cr↑ 25.4% YoY
Profitability
PositiveNet Income ₹916.52Cr
Gross Margin
— 
Market Cap
—Pending Data
Issue Size
₹9275.25Cr 
Industry
Healthcare 
P/E Ratio
—Pending Data
EPS
₹7.67Earnings Per Share
RoNW
10.57%Return on Net Worth

Risk Breakdown

Governance
39
High Risk
Financial
70
Moderate
Valuation
50
Expensive
Competition
55
Expensive
Dilution
70
Moderate
Promoter / Mgmt
60
Moderate

AI Summary

Manipal Health Enterprises Limited operates a pan-India network of 49 multispecialty hospitals with 13,037 licensed beds as of March 31, 2026, offering services from outpatient care to tertiary and quaternary treatments. The company reported revenue growth from ₹6,171.63 crore in FY24 to ₹10,335.75 crore in FY26, with profit after tax increasing from ₹533.20 crore to ₹916.52 crore over the same period, though profit moderated in FY26 after peaking in FY25. IPO proceeds of ₹5,952 crore will be used for debt repayment in its subsidiary Manipal Hospitals Private Limited, acquisition of a minority stake in Sahyadri Hospitals Private Limited, and general corporate purposes. The company holds significant healthcare accreditations, with 41 hospitals NABH-accredited and 24 laboratories NABL-accredited as of March 31, 2026.

Overall Verdict: Manipal Health Enterprises Limited presents a strong IPO opportunity backed by its position as one of India's largest private multispecialty hospital networks, consistent revenue growth, and improving profitability, though investors should monitor debt levels and the moderation in net profit growth in FY26.

Key Highlights

  • •Operates 49 hospitals with 13,037 licensed beds across 14 states and Union Territories as of March 31, 2026.
  • •Revenue increased from ₹6,171.63 crore in FY24 to ₹10,335.75 crore in FY26, reflecting strong growth.
  • •Profit after tax rose from ₹533.20 crore in FY24 to ₹916.52 crore in FY26, though it decreased from ₹1,081.67 crore in FY25.
  • •As of March 31, 2026, 41 hospitals were NABH-accredited and 24 laboratories were NABL-accredited.
  • •Performed approximately 5,980 robotic surgeries and 620 organ transplants during Fiscal 2026.
  • •IPO proceeds of ₹5,952 crore will be used for debt repayment (₹5,378 crore) and acquisition of minority stake in Sahyadri Hospitals (₹574 crore).
  • •Employed 11,064 doctors, 11,048 nurses, and 6,362 paramedics as of March 31, 2026.

Financial Performance

Revenue (Annual)

↑ +25.4% YoY

INR in Crores

Net Income (Annual)

↓ -15.3% YoY

INR in Crores

EBITDA vs PAT

EBITDA YoY

INR in Crores

EBITDA
PAT

Listing Timeline

IPO Opens2026-07-29
IPO Closes2026-07-31
Basis of Allotment2026-08-03
Refunds & Demat2026-08-02
Listing Date2026-08-05

Valuation Analysis

Issue Price₹560 - ₹590
Estimated Fair Value
Pending Data
Valuation Premium
Pending
vs Fair Value

Stock DNA

Growth
62
Governance
39
Profitability
70
Valuation
50
Competition
55
Execution
60

Pros vs Cons

Pros

  • Revenue grew at a CAGR of 29.4% from FY24 to FY26, reaching ₹10,335.75 crore in FY26.
  • ROCE of 21.88% and RoNW of 10.57% for FY26 indicate efficient use of capital.
  • Operates one of India's largest private hospital networks with 49 hospitals and 13,037 beds across 14 states.
  • Strong accreditation profile: 41 hospitals NABH-accredited and 24 laboratories NABL-accredited as of March 31, 2026.

Cons

  • Profit after tax declined from ₹1,081.67 crore in FY25 to ₹916.52 crore in FY26, showing moderation in profitability.
  • Debt levels are not disclosed in the prospectus, creating uncertainty about financial leverage.
  • The company's growth has been significantly driven by acquisitions, which may pose integration risks.

Financial Health

Revenue Growth
29.4% CAGR (FY24-FY26) (Excellent)

Institutional Signals

Anchor Investors
Undisclosed
VC Backing Tier
Undisclosed
Strategic Partners
Undisclosed

Manipal Health IPO Reddit Pulse & Sentiment

Real-time Reddit discussions & retail sentiment

No Public Data Available

We couldn't find any significant public discussions or retail sentiment threads for this IPO at the moment.

Disclaimer: These are raw community discussions aggregated from public forums. The AI summary and Reddit comments do not constitute financial advice. Always conduct your own independent research.

Manipal Health Stock — Frequently Asked Questions

Related Stock Reports

AceVector

AceVector

ACEVEC
0/100
View Report
German Green Steel and Power

German Green Steel and Power

GGSPL
0/100
View Report
Sai Urja Indo Ventures

Sai Urja Indo Ventures

SAIURJA
59/100
View Report
Bench Mark Infotech

Bench Mark Infotech

BMISL
0/100
View Report
Himalayan Solar

Himalayan Solar

HIMALAYAN
0/100
View Report
View All Active & Upcoming Stocks & IPOs View Stock & IPO Calendar

Market Terminology Explained

Confused by terms like GMP, Kostak, or Subject to Sauda? Read our detailed guides in the IPO Glossary to understand the terminology before you invest.

Grey Market Premium (GMP)Subject to SaudaASBAOffer for Sale (OFS)
View Full Glossary

Source Citation: All financial data and risk metrics are derived from the official prospectus filed with the regulator (SEBI DRHP/RHP). ViewIPO algorithms process this public data for informational purposes. Not financial advice.

Want to analyze another stock or IPO?

Search any stock, IPO, company, ticker or filing and get instant AI-powered analysis.

Frequently Asked Questions about Manipal Health

What is the expected listing price of Manipal Health?

The expected listing price depends on the live Grey Market Premium. Check the live GMP and expected listing price for Manipal Health on our Live GMP Tracker.